Israeli maker of GlucoTrack believes its noninvasive meter will encourage people with Type 2 diabetes to check glucose levels more often.
People with diabetes and impaired glucose tolerance are advised to spot-check their blood-glucose levels several times daily to reduce the risk of serious complications. That’s a lot of finger-pricking, considering that about 700 million people fall into one of those categories.
The Israeli company Integrity Applications put more than a decade into developing GlucoTrack, described as the first truly noninvasive system for self-monitoring glucose levels.
Instead of drawing blood, you clip the GlucoTrack sensor to your earlobe. A patented combination of ultrasonic, electromagnetic and thermal technologies works with a proprietary algorithm to measure physiological parameters correlated with glucose level.
Read the full story by Abigail Klein Leichman
